A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses

Journal article

David C Jackson, Yuk Fai Lau, Thuy Le, Andreas Suhrbier, Georgia Deliyannis, Christina Cheers, Corey Smith, Weiguang Zeng, Lorena E Brown

Proceedings of the National Academy of Sciences of the United States of America | Published : 2004